logo
logo
  • Product
    • Cloud
    • Cluster
      • Andromeda
    • System
    • Processor
    • Software
  • Applications
    • Natural Language Processing
    • Computer Vision
    • High-Performance Computing
    • Industries
      • Health & Pharma
      • Energy
      • Government
      • Scientific Computing
      • Financial Services
      • Web and Social Media
  • Resources
    • Customer Spotlights
    • Blog
    • Publications
    • Events
    • White Papers
  • Developers
    • Community
    • Developer Blog
    • Documentation
    • Cerebras Model Zoo
    • Request Access to SDK
  • Company
    • About
    • In the News
    • Awards
    • Press Releases
    • Press Kit
  • Join Us
    • Life at Cerebras
    • All openings
  • Get Demo
  • Search

Drug Discovery

  • Show all
  • Business
  • Chip
  • Machine Learning
  • Software
  • System
  • Drug Discovery
  • Blog
  • HPC
  • Developer Blog
ChipMachine LearningSoftwareDrug DiscoveryBlogHPCDeveloper Blog

November 14, 2022

Genomics in Unparalleled Resolution: Cerebras Wafer-Scale Cluster Trains Large Language Models on the Full COVID Genome Sequence

Our joint work with Argonne National Laboratory (ANL) and…


by Rebecca Lewington

ChipMachine LearningSystemDrug DiscoveryBlog

January 26, 2022

GlaxoSmithKline and Cerebras are Advancing the State of the Art in AI for Drug Discovery


by Rebecca Lewington

BusinessChipMachine LearningSystemDrug DiscoveryBlog

January 14, 2022

If You’re Doing Pharma and Life Sciences AI Research Without a Cerebras System, You’re Doing it Wrong

Cerebras AI accelerator systems make it possible to train…


by Rebecca Lewington

ChipMachine LearningSystemDrug DiscoveryBlog

December 14, 2021

A Big Chip for Big Science: Watching the COVID-19 Virus in Action

It’s hard to imagine a better example of “AI for good” than…


Avatar photoby Vishal Subbiah

ChipMachine LearningDrug DiscoveryBlog

June 16, 2021

Innovations in Virtual Drug Screening

Drug discovery has seen substantial innovation in recent…


by Natalia Vassilieva

ChipMachine LearningDrug DiscoveryBlog

April 26, 2021

Customer Blog: AstraZeneca’s Lars Lynne Hansen


by Rebecca Lewington

Drug Discovery

April 26, 2021

Customer Blog: Accelerating Drug Discovery with New AI Models


by Rebecca Lewington

© 2023 Cerebras. All rights reserved

Privacy Preference Center

Privacy Preferences

Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
Manage options Manage services Manage vendors Read more about these purposes
View preferences
{title} {title} {title}